A TQT Study of Effect of M2951 on Cardiac Repolarization

Conditions

• Healthy

Interventions

• DRUG: Placebo matched to M2951
• DRUG: Moxifloxacin
• DRUG: M2951 Low Dose
• DRUG: M2951 High Dose

Sponsor

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany